Curia Upgrades Aseptic Suites in Valladolid, Spain

Curia Global Inc., a global research, development and manufacturing organization, has completed a $4 million upgrade of its two aseptic suites in Valladolid, Spain in accordance with the EU’s GMP Annex 1 standards.

The central feature of the upgrade was the transition to a fully closed system, designed to strengthen process and product integrity while minimizing microbiological risk across all stages of production. Enhancements also focused on modernizing core equipment and systems, including the installation of advanced isolators, as well as upgrades to HVAC, pharmaceutical utilities, automation and sterilization-in-place processes.

“This investment at Valladolid reflects Curia’s commitment to delivering high-quality sterile manufacturing capabilities that align with the growth plans of our customers,” said Philip Macnabb, CEO of Curia. “These facility enhancements position us as a stronger partner when it comes to producing increasingly complex sterile products while maintaining the high standards of quality assurance that regulators and customers expect.”

By advancing its aseptic capabilities, Curia says it will be able to offer greater flexibility, reliability and speed.